20
Boehringer Ingelheim Pharma Gmbh & Co. Kg Ingelheim Am Rhein De, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Hyoscine, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2006-216 - Rev 00
This Chemical Type CEP, issued on June 05, 2014, remains in force until March 01, 2018, ensuring its reliability within the pharmaceutical industry.
Substance Number 2167 associated with this CEP further emphasizes